 | • レポートコード：20QY06-00686 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、アミホスチンのグローバル市場について種類別（400mg /回、500mg /回）、用途別（頭頸部癌アジュバント療法、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・アミホスチン市場の概要 ・世界の主要地域別アミホスチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のアミホスチン市場規模2015-2026：種類別（400mg /回、500mg /回） ・世界のアミホスチン市場規模2015-2026：用途別（頭頸部癌アジュバント療法、その他） ・アミホスチンの北米市場規模2015-2020 ・アミホスチンのヨーロッパ市場規模2015-2020 ・アミホスチンの中国市場規模2015-2020 ・アミホスチンの日本市場規模2015-2020 ・アミホスチンの東南アジア市場規模2015-2020 ・アミホスチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Clinigen、Sun Pharmaceutical、Taj Pharmaceuticals、Merro Pharmaceutical、Luye Pharma、Mingren Pharma） ・アミホスチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・アミホスチンの市場動向・機会・課題 ・調査の結論 |
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.
Consumption of amifostine mainly concentrates in North America. In 2016, the region consumed 780 K Unit, holding about 52% market share globally. The follower is Asia-Pacific, with about 41% consumption share.
The market is relatively concentrated and there are just a few suppliers in the market, such as Clinigen , Sun Pharmaceutical, Merro Pharmaceutical and so on. Clinigen acquired the business from AstraZeneca in the year of 2014 and signed an agreement with Cumberland in the year of 2016. Under the agreement, Cumberland acquired the exclusive rights to commercialize Ethyol in the United States. Merro Pharmaceutical own the largest sales share in China.
Amifostine shows good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment.
Market Analysis and Insights: Global Amifostine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Amifostine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Amifostine industry.
Based on our recent survey, we have several different scenarios about the Amifostine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 50 million in 2019. The market size of Amifostine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Amifostine Scope and Market Size
The global Amifostine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Amifostine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Amifostine market is segmented into
400mg/Dose
500mg/Dose
Segment by Application, the Amifostine market is segmented into
Head and Neck Cancer Adjuvant Therapy
Others
The Amifostine market is analysed and market size information is provided by regions (countries). Segment by Application, the Amifostine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Amifostine Market Share Analysis
Amifostine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Amifostine business, the date to enter into the Amifostine market, Amifostine product introduction, recent developments, etc.
The major vendors covered:
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
…
1 Amifostine Market Overview
1.1 Amifostine Product Scope
1.2 Amifostine Segment by Type
1.2.1 Global Amifostine Sales by Type (2020-2026)
1.2.2 400mg/Dose
1.2.3 500mg/Dose
1.3 Amifostine Segment by Application
1.3.1 Global Amifostine Sales Comparison by Application (2020-2026)
1.3.2 Head and Neck Cancer Adjuvant Therapy
1.3.3 Others
1.4 Amifostine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Amifostine Sales Growth Rate (2015-2026)
1.4.2 Global Amifostine Revenue and Growth Rate (2015-2026)
1.4.3 Global Amifostine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Amifostine Industry Impact
1.5.1 How the Covid-19 is Affecting the Amifostine Industry
1.5.1.1 Amifostine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Amifostine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Amifostine Players to Combat Covid-19 Impact
2 Amifostine Estimate and Forecast by Region
2.1 Global Amifostine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Amifostine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Amifostine Sales Market Share by Region (2015-2020)
2.2.2 Global Amifostine Revenue Market Share by Region (2015-2020)
2.3 Global Amifostine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Amifostine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Amifostine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Amifostine Estimates and Projections (2015-2026)
2.4.2 Europe Amifostine Estimates and Projections (2015-2026)
2.4.3 China Amifostine Estimates and Projections (2015-2026)
2.4.4 Japan Amifostine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Amifostine Estimates and Projections (2015-2026)
2.4.6 India Amifostine Estimates and Projections (2015-2026)
3 Global Amifostine Competition Landscape by Players
3.1 Global Top Amifostine Players by Sales (2015-2020)
3.2 Global Top Amifostine Players by Revenue (2015-2020)
3.3 Global Amifostine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amifostine as of 2019)
3.4 Global Amifostine Average Price by Company (2015-2020)
3.5 Manufacturers Amifostine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Amifostine Players (Opinion Leaders)
4 Global Amifostine Market Size by Type
4.1 Global Amifostine Historic Market Review by Type (2015-2020)
4.1.1 Global Amifostine Sales Market Share by Type (2015-2020)
4.1.2 Global Amifostine Revenue Market Share by Type (2015-2020)
4.1.3 Global Amifostine Price by Type (2014-2020)
4.2 Global Amifostine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Amifostine Sales Forecast by Type (2021-2026)
4.2.2 Global Amifostine Revenue Forecast by Type (2021-2026)
4.2.3 Global Amifostine Price Forecast by Type (2021-2026)
5 Global Amifostine Market Size by Application
5.1 Global Amifostine Historic Market Review by Application (2015-2020)
5.1.1 Global Amifostine Sales Market Share by Application (2015-2020)
5.1.2 Global Amifostine Revenue Market Share by Application (2015-2020)
5.1.3 Global Amifostine Price by Application (2015-2020)
5.2 Global Amifostine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Amifostine Sales Forecast by Application (2021-2026)
5.2.2 Global Amifostine Revenue Forecast by Application (2021-2026)
5.2.3 Global Amifostine Price Forecast by Application (2021-2026)
3 North America Amifostine Market Facts & Figures
3.2 North America Amifostine Sales Market Share by Company (2015-2020)
3.3 North America Amifostine Sales Market Share by Type (2015-2020)
3.4 North America Amifostine Sales Market Share by Application (2015-2020)
4 Europe Amifostine Market Facts & Figures
4.2 Europe Amifostine Sales Market Share by Company (2015-2020)
4.3 Europe Amifostine Sales Market Share by Type (2015-2020)
4.4 Europe Amifostine Sales Market Share by Application (2015-2020)
5 China Amifostine Market Facts & Figures
5.2 China Amifostine Sales Market Share by Company (2015-2020)
5.3 China Amifostine Sales Market Share by Type (2015-2020)
5.4 China Amifostine Sales Market Share by Application (2015-2020)
6 Japan Amifostine Market Facts & Figures
6.2 Japan Amifostine Sales Market Share by Company (2015-2020)
6.3 Japan Amifostine Sales Market Share by Type (2015-2020)
6.4 Japan Amifostine Sales Market Share by Application (2015-2020)
7 Southeast Asia Amifostine Market Facts & Figures
7.2 Southeast Asia Amifostine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Amifostine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Amifostine Sales Market Share by Application (2015-2020)
8 India Amifostine Market Facts & Figures
8.2 India Amifostine Sales Market Share by Company (2015-2020)
8.3 India Amifostine Sales Market Share by Type (2015-2020)
8.4 India Amifostine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Amifostine Business
12.1 Clinigen
12.1.1 Clinigen Amifostine Corporation Information
12.1.2 Clinigen Amifostine Business Overview and Total Revenue
12.1.3 Clinigen Amifostine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Clinigen Amifostine Products Offered
12.1.5 Clinigen Recent Development
12.2 Sun Pharmaceutical
12.2.1 Sun Pharmaceutical Amifostine Corporation Information
12.2.2 Sun Pharmaceutical Amifostine Business Overview and Total Revenue
12.2.3 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sun Pharmaceutical Amifostine Products Offered
12.2.5 Sun Pharmaceutical Recent Development
12.3 Taj Pharmaceuticals
12.3.1 Taj Pharmaceuticals Amifostine Corporation Information
12.3.2 Taj Pharmaceuticals Amifostine Business Overview and Total Revenue
12.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Taj Pharmaceuticals Amifostine Products Offered
12.3.5 Taj Pharmaceuticals Recent Development
12.4 Merro Pharmaceutical
12.4.1 Merro Pharmaceutical Amifostine Corporation Information
12.4.2 Merro Pharmaceutical Amifostine Business Overview and Total Revenue
12.4.3 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merro Pharmaceutical Amifostine Products Offered
12.4.5 Merro Pharmaceutical Recent Development
12.5 Luye Pharma
12.5.1 Luye Pharma Amifostine Corporation Information
12.5.2 Luye Pharma Amifostine Business Overview and Total Revenue
12.5.3 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Luye Pharma Amifostine Products Offered
12.5.5 Luye Pharma Recent Development
12.6 Mingren Pharma
12.6.1 Mingren Pharma Amifostine Corporation Information
12.6.2 Mingren Pharma Amifostine Business Overview and Total Revenue
12.6.3 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mingren Pharma Amifostine Products Offered
12.6.5 Mingren Pharma Recent Development
…
13 Amifostine Manufacturing Cost Analysis
13.1 Amifostine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Amifostine
13.4 Amifostine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Amifostine Distributors List
14.3 Amifostine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Amifostine Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Amifostine Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Amifostine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Amifostine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Amifostine Players to Combat Covid-19 Impact
Table 8. Global Market Amifostine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Amifostine Sales (MT) by Region (2015-2020)
Table 10. Global Amifostine Sales Market Share by Region (2015-2020)
Table 11. Global Amifostine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Amifostine Revenue Share by Region (2015-2020)
Table 13. Global Amifostine Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Amifostine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Amifostine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Amifostine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Amifostine (MT) of Key Companies (2015-2020)
Table 18. Global Amifostine Sales Share by Company (2015-2020)
Table 19. Global Amifostine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Amifostine Revenue Share by Company (2015-2020)
Table 21. Global Amifostine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amifostine as of 2019)
Table 22. Global Amifostine Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Amifostine Manufacturing Sites and Area Served
Table 24. Manufacturers Amifostine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Amifostine Players
Table 27. Global Amifostine Sales (MT) by Type (2015-2020)
Table 28. Global Amifostine Sales Share by Type (2015-2020)
Table 29. Global Amifostine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Amifostine Price (MT) by Type (2015-2020)
Table 31. Global Amifostine Sales Share by Type (2021-2026)
Table 32. Global Amifostine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Amifostine Revenue Share by Type (2021-2026)
Table 34. Global Amifostine Price (MT) by Type (2021-2026)
Table 35. Global Amifostine Sales (MT) by Application (2015-2020)
Table 36. Global Amifostine Sales Share by Application (2015-2020)
Table 37. Global Amifostine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Amifostine Price (MT) by Application (2015-2020)
Table 39. Global Amifostine Sales (MT) by Application (2021-2026)
Table 40. Global Amifostine Sales Share by Application (2021-2026)
Table 41. Global Amifostine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Amifostine Revenue Share by Application (2021-2026)
Table 43. Global Amifostine Price (MT) by Application (2021-2026)
Table 44. United States Amifostine Sales (MT) by Company (2015-2020)
Table 45. United States Amifostine Sales Market Share by Company (2015-2020)
Table 46. United States Amifostine Sales (MT) by Type (2015-2020)
Table 47. United States Amifostine Sales Market Share by Type (2015-2020)
Table 48. United States Amifostine Sales (MT) by Application (2015-2020)
Table 49. United States Amifostine Sales Market Share by Application (2015-2020)
Table 50. Europe Amifostine Sales (MT) by Company (2015-2020)
Table 51. Europe Amifostine Sales Market Share by Company (2015-2020)
Table 52. Europe Amifostine Sales (MT) by Type (2015-2020)
Table 53. Europe Amifostine Sales Market Share by Type (2015-2020)
Table 54. Europe Amifostine Sales (MT) by Application (2015-2020)
Table 55. Europe Amifostine Sales Market Share by Type (2015-2020)
Table 56. China Amifostine Sales (MT) by Company (2015-2020)
Table 57. China Amifostine Sales Market Share by Company (2015-2020)
Table 58. China Amifostine Sales (MT) by Type (2015-2020)
Table 59. China Amifostine Sales Market Share by Type (2015-2020)
Table 60. China Amifostine Sales (MT) by Application (2015-2020)
Table 61. China Amifostine Sales Market Share by Application (2015-2020)
Table 62. Japan Amifostine Sales (MT) by Company (2015-2020)
Table 63. Japan Amifostine Sales Market Share by Company (2015-2020)
Table 64. Japan Amifostine Sales (MT) by Type (2015-2020)
Table 65. Japan Amifostine Sales Market Share by Type (2015-2020)
Table 66. Japan Amifostine Sales (MT) by Application (2015-2020)
Table 67. Japan Amifostine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Amifostine Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Amifostine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Amifostine Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Amifostine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Amifostine Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Amifostine Sales Market Share by Application (2015-2020)
Table 74. India Amifostine Sales (MT) by Company (2015-2020)
Table 75. India Amifostine Sales Market Share by Company (2015-2020)
Table 76. India Amifostine Sales (MT) by Type (2015-2020)
Table 77. India Amifostine Sales Market Share by Type (2015-2020)
Table 78. India Amifostine Sales (MT) by Application (2015-2020)
Table 79. India Amifostine Sales Market Share by Application (2015-2020)
Table 80. Clinigen Corporation Information
Table 81. Clinigen Description and Business Overview
Table 82. Clinigen Amifostine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Clinigen Amifostine Product
Table 84. Clinigen Recent Development
Table 85. Sun Pharmaceutical Corporation Information
Table 86. Sun Pharmaceutical Description and Business Overview
Table 87. Sun Pharmaceutical Amifostine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Sun Pharmaceutical Amifostine Product
Table 89. Sun Pharmaceutical Recent Development
Table 90. Taj Pharmaceuticals Corporation Information
Table 91. Taj Pharmaceuticals Description and Business Overview
Table 92. Taj Pharmaceuticals Amifostine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Taj Pharmaceuticals Amifostine Product
Table 94. Taj Pharmaceuticals Recent Development
Table 95. Merro Pharmaceutical Corporation Information
Table 96. Merro Pharmaceutical Description and Business Overview
Table 97. Merro Pharmaceutical Amifostine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Merro Pharmaceutical Amifostine Product
Table 99. Merro Pharmaceutical Recent Development
Table 100. Luye Pharma Corporation Information
Table 101. Luye Pharma Description and Business Overview
Table 102. Luye Pharma Amifostine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Luye Pharma Amifostine Product
Table 104. Luye Pharma Recent Development
Table . Mingren Pharma Corporation Information
Table . Mingren Pharma Description and Business Overview
Table . Mingren Pharma Amifostine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Mingren Pharma Amifostine Product
Table . Mingren Pharma Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Amifostine Distributors List
Table 113. Amifostine Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Amifostine Product Picture
Figure 2. Global Amifostine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Amifostine Market Share by Application in 2020 & 2026
Figure 6. Head and Neck Cancer Adjuvant Therapy Examples
Figure 7. Others Examples
Figure 8. Global Amifostine Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Amifostine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Amifostine Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 11. Global Amifostine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Amifostine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Amifostine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Amifostine Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Amifostine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Amifostine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Amifostine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Amifostine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Amifostine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Amifostine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Amifostine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Amifostine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Amifostine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Amifostine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Amifostine Players Market Share by Revenue in Amifostine 2015 & 2019
Figure 26. Amifostine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Amifostine Revenue Share by Type (2015-2020)
Figure 28. Global Amifostine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Amifostine Revenue Share by Application (2015-2020)
Figure 30. Global Amifostine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Amifostine Sales Market Share by Type in 2019
Figure 32. United States Amifostine Sales Market Share by Type in 2019
Figure 33. Europe Amifostine Sales Market Share by Company in 2019
Figure 34. Europe Amifostine Sales Market Share by Type in 2019
Figure 35. Europe Amifostine Sales Market Share by Application in 2019
Figure 36. China Amifostine Sales Market Share by Company in 2019
Figure 37. China Amifostine Sales Market Share by Type in 2019
Figure 38. China Amifostine Sales Market Share by Application in 2019
Figure 39. Japan Amifostine Sales Market Share by Company in 2019
Figure 40. Japan Amifostine Sales Market Share by Type in 2019
Figure 41. Japan Amifostine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Amifostine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Amifostine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Amifostine Sales Market Share by Application in 2019
Figure 45. India Amifostine Sales Market Share by Company in 2019
Figure 46. India Amifostine Sales Market Share by Type in 2019
Figure 47. India Amifostine Sales Market Share by Application in 2019
Figure 48. Clinigen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Merro Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Luye Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Mingren Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Key Raw Materials Price Trend
Figure 55. Manufacturing Cost Structure of Amifostine
Figure 56. Manufacturing Process Analysis of Amifostine
Figure 57. Amifostine Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
頭頸部がん治療薬/治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Head and Neck Cancer Drugs/Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1466.9 million by 2025, from USD 1255.8 million in 2019. …- 定量吸入器デバイスの世界市場レポート2020 Market Analysis and Insights: Global Metered Dose Inhaler Devices Market The global Metered Dose Inhaler Devices market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Metered Dose Inhaler Devices Scope and Mark…
- 加圧式定量吸入器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pressurized Metered Dose Inhaler market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pressurized …
- 定量吸入器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Metered Dose Inhalers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metered Dose Inhalers m…
- 放射線量モニタリングの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Radiation Dose Monitoring market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.4% in the forecast period of 2020 to 2025 and will expected to reach USD 2409.7 million by 2025, from USD 2024.6 million in 2019. The Radiation …